9 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
preclinical data at American Epilepsy Society (AES) and American Society for Experimental Neurotherapeutics (ASENT) Annual Meetings and in publication Drug … Epilepsy Society (AES) Annual Meeting in December 2023, the publication Drug Development Research in February 2024 and the American Society
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
13 Nov 23
Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
4:10pm
Epilepsy Society (AES) Annual Meeting -
- Agreement reached with U.S. FDA on study design and analysis approach for Phase 3 safety study of IV tramadol … to BAER-101, we look forward to presenting the full dataset of August’s promising preclinical results at the American Epilepsy Society Annual Meeting
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
14 Aug 20
Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
8:30am
Medicine Meeting hosted by the American Society of Regional Anesthesia and Pain Medicine.
The e-poster (816) titled “Intravenous Tramadol is Effective
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
11 May 20
Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
9:00am
hosted by the American Society of Regional Anesthesia and Pain Medicine (“ASRA”).
The e-poster (816) titled “Intravenous Tramadol is Effective
8-K
sxral
23 Apr 20
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
9:00am
8-K
EX-99.1
41dxyj
23 Apr 20
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
9:00am
8-K
EX-99.1
8ery5g0
30 Mar 20
Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
9:01am
8-K
EX-99.1
fmaus rz7j1z97n
4 Nov 19
Avenue Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
9:00am
- Prev
- 1
- Next